Hanyun Ren
Overview
Explore the profile of Hanyun Ren including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
719
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang H, Suo S, Li D, Li J, Liu L, Lu Y, et al.
Leukemia
. 2025 Mar;
PMID: 40074854
No abstract available.
2.
Xue C, Liu W, Li Y, Yin Y, Tang B, Zhu J, et al.
Stem Cell Res Ther
. 2025 Mar;
16(1):108.
PMID: 40025564
Background: Our previous study revealed that mesenchymal stem cells (MSCs) can secrete large amounts of the chemokine CCL2 under inflammatory conditions and alleviate idiopathic pneumonia syndrome (IPS) by promoting regulatory...
3.
Liu Y, Liang Z, Ren H, Dong Y, Liu W, Yin Y, et al.
Ann Med
. 2025 Jan;
57(1):2447402.
PMID: 39749649
Background: Cord blood (CB) is widely used in treating haematologic disorders due to its broad availability, tolerance to significant histocompatibility antigen disparities, and low incidence of chronic graft-versus-host disease (cGVHD)....
4.
Wang Y, Wang Q, Ren H, Dong Y, Wang Q, Liang Z, et al.
Front Oncol
. 2024 Dec;
14:1465334.
PMID: 39717745
Introduction: Acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) constitute myeloid malignancies, and allogeneic hematopoietic stem cell transplantation (allo-HSCT) is considered as a potentially optimal approach for achieving a long...
5.
Li C, Zhou K, Hu Y, Zou D, Chen L, Chen B, et al.
JAMA Oncol
. 2024 Nov;
PMID: 39509090
Importance: Equecabtagene autoleucel (eque-cel), a fully human-derived B-cell maturation antigen-targeting chimeric antigen receptor (CAR) T-cell therapy, has exhibited potential for the treatment of relapsed or refractory multiple myeloma (RRMM), and...
6.
Tang B, Qin C, Liu H, Miao S, Xue C, Wang Z, et al.
Int Immunol
. 2024 May;
36(10):541-552.
PMID: 38778574
Lymphocyte trafficking via chemokine receptors such as C-C chemokine receptor 5 (CCR5) and CXCR3 plays a critical role in the pathogenesis of acute graft-versus-host disease (aGVHD). Our previous studies showed...
7.
Wang L, Gao L, Liang Z, Cen X, Ren H, Dong Y
Leuk Lymphoma
. 2023 Dec;
65(3):353-362.
PMID: 38069781
Unfit acute myeloid leukemia and high-risk myelodysplastic syndrome patients with prolonged neutropenia demand coadministration of venetoclax and azoles. However, venetoclax dosing under drug-drug interaction with azoles remains controversial. Therapeutic drug...
8.
Zhai Y, Wang Q, Ji L, Ren H, Dong Y, Yang F, et al.
Cancer Med
. 2023 Dec;
12(24):21592-21604.
PMID: 38062912
Background: Chromosomal translocations involving core binding factor (CBF) genes account for 15% of adult acute myeloid leukemia (AML) cases in China. Despite being classified as favorable-risk by European Leukemia Net...
9.
Zhu J, Wang Q, Ren H, Dong Y, Yin Y, Wang Q, et al.
Front Immunol
. 2023 Nov;
14:1274492.
PMID: 37928518
Background: The widespread adoption of Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT) has significantly improved the survival rates of patients with hematological malignancies. However, Graft-Versus-Host Disease (GVHD) remains a formidable complication,...
10.
Xia Z, Leng Y, Fang B, Liang Y, Li W, Fu C, et al.
BMC Cancer
. 2023 Oct;
23(1):980.
PMID: 37838670
Background: Aponermin, a circularly permuted tumor necrosis factor-related apoptosis-inducing ligand, is a potential death receptor 4/5-targeted antitumour candidate. Previous phase 1/2 studies have demonstrated the efficacy of aponermin in patients...